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Abstract 
We report on the synthesis and properties of a photoactivatable caged RGD peptide and its 
application for phototriggering integrin and cell binding to surfaces. We analyzed in detail (i) 
the differences in the integrin binding affinity of the caged and uncaged forms via quartz 
crystal microbalance (QCM) studies, (ii) the efficiency and yield of the photolytic uncaging 
reaction, (iii) the biocompatibility of the photolysis byproducts and irradiation conditions and 
(iv) the possibility of site, temporal and density control of integrin binding and, therefore, 
human cell attachment, (v) the possibility of in situ generation of cell patterns and cell 
gradients by controlling the exposure. These studies provide a clear picture of the potential 
and limitations of caged ligands for integrin-mediated cell adhesion and demonstrate the 
application of this approach to control and study other types of cell interactions and response. 
Introduction 
Controlled and selective adhesion and release of cells to surfaces is an important issue for any 
progress in cell biology and tissue engineering. Different strategies have been reported that 
use thermally,1 electrochemically2 or photochemically3 responsive surfaces to manipulate cell 
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attachment and detachment (see reference 4 for a recent review). Among the possible cell-
friendly stimuli, light-based systems are the ones that have demonstrated the most accurate 
spatiotemporal control of cellular response and flexibility in terms of material of use. 
Reported photochemical approaches to trigger cell adhesion rely on a light-triggered exposure 
of cell adhesive peptides at the surface (usually RGD5 able to be recognized by integrins at 
the cell membrane) via (i) a phase transition of RGD-containing amphiphilic peptides,3c (ii) 
photoisomerization of azobenzene linkers units linking the RGD peptide to the surface,3d-f or 
(iii) photocleavage of protecting groups (cages) directly attached to the surface immobilized 
RGD structure.3a,b Reported light-based strategies to trigger cell detachment include 
photodegradable gels6 and photocleavable linkers that detach RGD ligands (to which cells 
attach) from the surface of the material upon light exposure. Amongst these strategies, 
photocleavable caging groups3a,b,7 are the only ones that are not material-specific, allow 
dynamic variation and precise tuning of the stimulus over time, and provide direct control 
over the molecular interactions at the binding site.  
We have reported a photolabile cyclo[RGD(DMNPB)fK] (Figure 1) which is a derivative of 
cyclo[RGDfK]5 containing a 3-(4,5-dimethoxy-2-nitrophenyl)-2-butyl ester (DMNPB) 
photolabile group at the COOH group of the aspartate unit.3b This position acts as a ligand for 
one of the two bivalent cations involved in the RGD-integrin integrin αVβ3 binding site.8 
PEGylated surfaces modified with cyclo[RGD(DMNPB)fK] did not promote cell adhesion. 
Upon light-exposure, the DMNPB group was cleaved from the peptide and cell adhesion 
occurred. This peptide was used to phototrigger attachment of mouse fibroblast 3T3 cells to 
cell-repellent surfaces. In a similar approach, a caged linear peptide YAVTGRGDSPASS 
with an o-nitrobenzyl group introduced at the amide between the Gly and Arg residues has 
also demonstrated the ability to phototrigger attachment of HeLa cells.3a However, apart from 
impressive proof-of-principle results,3a,b,7 no studies have been reported analysing the 
physico-chemical and biological properties of the photosensitive caged RGDs. In this 
manuscript, we report a detailed study of the properties of cyclo[RGD(DMNPB)fK] as cell 
adhesion phototrigger including (i) the differences in the integrin binding affinity of the caged 
and uncaged forms via quartz crystal microbalance (QCM) studies, (ii) the efficiency of the 
photolytic uncaging reaction, (iii) the human cell biocompatibility of the photolysis 
byproducts and irradiation conditions and (iv) the possibility of site, temporal and density 
control of integrin binding and, therefore, cell attachment. The possibility of in situ generation 
of cell patterns and cell gradients by controlling the exposure dose will also be demonstrated. 
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These studies provide a clear picture of the potential and limitations of caged ligands for 
integrin-mediated cell adhesion and should stimulate the application of this approach to 
control and study other kind of cell interactions and response. 
 
 
Experimental 
 
Cyclo[RGD(DMNPB)fK] was synthesized using an improved version of the previously 
reported protocol3b that is included as supporting information. The synthesis and 
characterisation of the DMNPB-caged silane for the photolysis studies of surface-bound 
chromophore is also included as supporting information. 
 
Cleaning of substrates: Glass slides were cleaned by soaking in Piranha solution 
(H2SO4(conc.)/H2O2(30%) 5/1) for one night, rinsing with Milli-Q water, absolute ethanol and 
dried with a N2 stream. Gold-coated substrates for cell experiments were prepared by 
sequential deposition of chromium (20 Å) and gold (200 Å) films onto clean glass slides of 
round shape (diameter 12mm) via a thermal evaporator (Edward FL 400, 5 x 10-6mbar, 2Å/s). 
 
RGD functionalised self-assembled monolayers (SAMs) on gold substrates: Gold-coated 
substrates or QCM gold crystals were incubated overnight in a 1.0 mM mixed thiol solution 
of HS(CH2)11(OCH2CH2)3OH and HS(CH2)11(OCH2CH2)6OCH2COOH thiols (ProChimia TH 
001-m11.n3-0,2 and TH 003-m11.n6-0,1) in absolute ethanol. Cell culture experiments were 
performed on 4% COOH SAMs, whereas other ratios were used for the QCM experiments 
(see results part). The substrates were rinsed with ethanol and Milli-Q water and then 
incubated in an aqueous solution of 0.2M EDC (N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride), 0.1M NHS (N-hydroxysuccinimide), 0.1M 2-(N-morpho)-
ethanesulfonic acid and 0.5M NaCl. After 15min the solution was removed and the substrates 
were washed with deionized water and incubated in a 0.5 mg/mL solution of the RGD peptide 
(either cyclo[RGD(DMNPB)fK] or commercially available cyclo[RGDfK] or the negative 
control cyclo(RADfK) from Peptides International, USA) for 45min. The substrates were 
rinsed with PBS and dried with an N2 stream. 
 
IR characterisation of the SAMs: IR spectra (4000-400 cm-1 with a resolution of 4 cm-1 and 
1000 scans) were recorded with a Nicolet Magna-IR 850 Series II spectrometer. 
Measurements were performed on 50% COOH terminated SAMs. 
 4 
 
Light irradiation of the substrates: Substrates for photolysis measurements and cell 
experiments were irradiated using a Xe-lamp coupled to a monochromator (Polychrome V, 
Till Photonics). Irradiation wavelength and irradiance were 350 nm and 0.6 mW cm-2 
respectively. For masked irradiation a quartz substrate containing a chrome micropattern 
(100µm chrome stripes with 200µm spacing) was placed on the substrates during exposure. 
The substrates were rinsed with THF and Milli-Q water to remove photolysis products from 
the surface layer except for the cells experiments with in situ exposure. In this case the cell 
culture dish without lid was illuminated 5 minutes from the top, the light passed through the 
culture medium and the photolysis products remained in the medium. The photolysis 
conversion and quatum yield of surface bound chromophores were calculated following the 
methods and models specified in 9. 
 
QCM experiments: QCM measurements were carried out with a Q-Sense E1 Microbalance 
(Q-Sense, Göteborg, Sweden) using a window cell (QWM 401 from Q-Sense) which allowed 
in situ irradiation with a 365 nm LED source (NT65-940, Edmund Optics, Irradiance ∼ 4.5 
mWcm-2 at the sample position). Experiments were performed on gold-coated quartz crystals 
(QS-QSX-301, Q-Sense), functionalized with RGD peptides as specified before at a 
controlled temperature of 25 °C (±0.05 °C). The solutions were injected at 50 µL/min flow 
rate. To switch between solutions, the flow was interrupted for a few seconds. The changes in 
the dissipation and normalized frequency, ∆f = ∆fn/n, presented in this work, correspond to 
values obtained for the third overtone (n = 3). 
Integrin αVβ3 (YO Proteins AB, Sweden) solutions were prepared in 50 mM Tris-HCl (pH = 
7.4), 150 mM NaCl, 2mM MgCl2.6H2O, 1 mM MnCl2.2H2O. An integrin concentration of 
∼20 µg mL-1 was used unless otherwise stated. 
A typical QCM experiment for integrin binding comprised the following steps. First the 
baseline was stabilized by flowing buffer solution into the QCM chamber, followed by 
injection of integrin solution at a flow rate of 50 µL min-1 during 4 minutes 30 seconds. The 
flow was stopped and the integrin was left to react with the surface for 35 min A rinsing step 
with buffer removed non-adsorbed protein from the QCM chamber. The integrin 
concentration of ∼20 µg mL-1 was selected as best compromise between the adsorbed and the 
consumed protein amounts after performing experiments at 2, 20 and 200 µg mL-1 (see Figure 
D supporting information). 
 
5 
Cell culture: Human umbilical vein endothelial cells (HUVECs) were isolated and cultured in 
M199 basal medium (Sigma, M4530) supplemented with 2mM L-glutamine, 1000UmL-1 
penicillin, and 100mgL-1 streptomycin (Sigma), ECGS supplement (Sigma, E-2759), sodium 
heparin (Sigma, H-3393) and 20% of fetal calf serum (FCS) as previously described.10 The 
Cal 72 osteoblast cell line was obtained from ATCC and cultured as described.11 Mouse 
fibroblasts (NIH3T3) were cultured in DMEM medium (Invitrogen, Germany) supplemented 
with 10% fetal bovine serum (FBS), 1% L-glutamine (Invitrogen) at 37 °C and 10% CO2. 
Human foreskin fibroblasts were isolated from human foreskin tissue and cultured as 
previously described.12 Cells were incubated at 37°C in a 5% carbon dioxide environment. 
Before plating on the quartz substrates, cells were trypsinized with 0.25 % trypsin and 1mM 
EDTA in Hanks’ buffered salt solution. All experiments were conducted at 105 cells/mL and 
HUVEC and human foreskin fibroblasts at passages 2 to 4. RGD-modified substrates were 
sterilized with ethanol 70% and then rinsed with PBS before cell seeding. 
Cell patterns: Masked irradiated substrates containing 200µm light-exposed stripes separated 
by 100µm were sterilized with ethanol 70% and rinsed with PBS buffer. Human umbilical 
vein endothelial cells (HUVECs, grown as described) were seeded on the substrates and 
incubated at 37°C in a 5% carbon dioxide environment. After 4h the medium (containing non-
attached cells) was exchanged. Digital microscopic images were obtained with a phase 
contrast or fluorescence microscopy.
Cell gradients: Quartz substrates were irradiated using a custom-built setup which allows 
automated writing of micrometric patterns with adjustable light intensity and selectable 
wavelength.13 The setup is based on an inverted microscope (Leica DM-IRM) fixed onto an 
optical table. A laser at 404 nm (Z-laser Optoelektronik GmbH) is routed through a beam 
expander and a dual axis galvanometer-based optical scanner (Edmund Optics GmbH) into 
the microscope through the side port. The scanner and other parts of the setup are controlled 
with custom developed software (Delphi) through an AD/DA-IO card (BMC Messsysteme 
GmbH) and monitored with a digital camera (Oscar, Allied Vision Technologies GmbH), thus 
allowing automated irradiation of any chosen pattern in the field of view during any selected 
time at micrometer resolution. The patterns were written as three rectangle fields of 150 µm 
width and 900 µm length using different exposure doses corresponding to 25, 100 and 50 % 
of the maximum irradiation dose. 
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Results and discussion 
Cyclo[RGD(DMNPB)fK] was synthesized using an improved version of the previously 
reported protocol.3b The details for the synthesis of the DMNPB caged aspartic acid and the 
conditions for solid phase synthesis of the peptide as well as for the purification are provided 
as supporting information to this manuscript. 
Photolytic properties of cyclo[RGD(DMNPB)fK] in solution and surface bound 
The photolytic reaction of cyclo[RGD(DMNPB)fK] upon light exposure to yield uncaged 
cyclo[RGDfK] is represented in Figure 1. The photocleavage involves a light-induced 
abstraction of a benzylic H atom by the excited nitro group and a β-elimination to form the o-
nitrostyrene derivative.14 The progress of the reaction was followed by the change in the UV 
spectrum of a solution of cyclo[RGD(DMNPB)fK] upon light exposure. Irradiation for times 
up to 31 min caused a decrease in the absorption maximum around 360 nm, an increase in the 
absorption maximum around 300 nm, and the appearance of a shoulder at λ>400 nm. These 
changes were also observed during irradiation of DMNPB-caged glutamate14a and are 
associated to the absorbance of the photolytic byproducts. Longer exposure doses caused a 
further change in the profile of the UV spectrum: the absorption maximum around 360 nm 
decreased again, while the shoulder at λ>400 nm remained almost unchanged. The change in 
the spectrum is associated with photochemical side reactions of the byproducts. Quantitative 
HPLC analysis of a 26 min irradiated solution (figure C supporting information) revealed the 
presence of 36% free cyclo[RGDfK]. HPLC analysis of a solution after 90 minutes irradiation 
revealed 92% free cyclo[RGDfK], confirming high chemical yield of the photolytic reaction. 
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Figure 1: A) Photolytic reaction of cyclo[RGD(DMNPB)fK] including the photolysis 
byproduct; B) UV spectra of a 0.05 mM solution of cyclo[RGD(DMNPB)fK] in PBS (pH 7.4) 
upon irradiation at 360 nm for increasing times. The UV spectrum of cyclo[RGDfK] at the 
same concentration is also shown for comparison. C) UV spectra of a quartz substrate 
modified with DMNPB-derivatized silane upon irradiation at λ=365 nm in PBS buffer (pH 
7.4) for increasing times and after washing to remove the cleaved chromophore. 
 
In order to follow the photolysis of DMNPB cage at the surface, we used DMNPB-protected, 
COOH terminated organosilane as model compound (see scheme in figure 1C) for direct 
surface anchoring (see supporting information for details). This allowed us to obtain surface 
densities of chromophore high enough for direct detection of the chromophore by UV 
spectroscopy on quartz substrates (figure 1C). Layers with a surface density of the 
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chromophore around 3.7 x 1014 molecs cm-2 were prepared and irradiated. Upon exposure and 
washing, the UV spectrum showed a significant decrease in the UV absorbance, indicating 
removal of the chromophore from the surface. However, a residual absorbance at wavelengths 
>300 nm was detected at full exposure (i.e. when the spectrum did not further change for 
longer exposure times), indicating the presence of surface bound chromophores after full 
uncaging, most likely due to photoactivated side-reactions of the styrene derivative at the 
surface. These results suggest that the exposed surface does not only contain the uncaged 
group (COOH in this case, or cyclo(RGDFK) in the next experiments), but also unspecifically 
reattached (or adsorbed) chromophores. This could be a limitation of our strategy in the 
biological application. However, the QCM and the cell results below will demonstrate that 
this was not the case for integrin binding to the uncaged surfaces. 
 
Immobilization of cyclo[RGD(DMNPB)fK] onto COOH terminated SAMs 
Carboxy-terminated, self-assembled monolayers (SAMs) of pegylated thiols on gold 
substrates were used as well-known biocompatible model surface layers for the experiments 
with integrins and cells.15 These are known to be protein and cell-repellent surfaces and, 
therefore, they could allow us to visualize and to quantify RGD-specific coupling or integrins 
or cells to the surface. Bicomponent SAMs containing different concentrations of COOH- (50 
to 1%) and OH-terminated thiols were prepared for the different applications and caged and 
non-caged cyclo[RGDfK] were covalently attached via the amine group of the Lys side chain 
using NHS/EDC standard coupling conditions. The coupling of the RGD to the SAM was 
confirmed by IR spectroscopy, as shown in Figure 2 for 50% COOH terminated SAMs. The 
Amide I (∼1680cm-1, C=O stretching vibration) and amide II (∼1530cm-1, N-H bending 
vibration and C-N stretching vibration) bands of the peptide were clearly visible and 
confirmed the presence of the RGD peptide at the surface. 
2000 1800 1600 1400 1200 1000 800
cm-1
-COOH (50%) terminated SAM
SAM + cyclo[RGD(DMNPB)fK]
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Figure 2: IR spectra of 50% COOH-terminated SAM after coupling cyclo[RGD(DMNPB)fK] 
peptide. The IR spectrum of cyclo[RGD(DMNPB)fK] powder can be found as supporting 
information (Figure B). 
 
Integrin affinity to cyclo[RGD(DMNPB)fK] studied by QCM-D 
The adsorption of integrin αVβ3 to substrates modified with cyclo[RGD(DMNPB)fK] prior 
and after irradiation was tested with QCM-D measurements. We first identified the best 
surface composition for maximizing RGD-mediated integrin binding and minimizing non-
specific interactions of the protein with the surface layer.16 For this purpose, QCM crystals 
were modified with SAMs containing 0.5 to 4% of the COOH terminated thiol, reacted with 
cyclo(RGDfK) and exposed to integrin solution. The coupling of the peptide involves a small 
mass change and could not be detected with the QCM when using SAMs with surface 
concentration of COOH groups ≤4%. However, a clear change in the resonance frequency 
was observed in the QCM curves upon integrin injection. Figure 3 shows the frequency shifts 
obtained for the different compositions. Maximum binding was observed for the 
cyclo(RGDfK) surface layers containing 1% COOH. As negative control for testing non-
specific binding cyclo(RADfK) was used. QCM crystals modified with 4% COOH-terminated 
layers modified with RAD showed a very weak frequency change upon integrin loading. 
These results indicate that integrin binding onto cyclo(RGDfK)-modified surfaces is specific 
and only mediated by the RGD peptide. As an additional control, binding experiments were 
performed without adding Mn2+ and Mg2+ in the buffer solution, since these cations are 
known to participate in the RGD-integrin binding site. A frequency shift <5 Hz (see Figure E 
in Supporting Information) confirmed that integrin immobilization occurs via recognition of 
the RGD ligand at the surface. 
 
Similar experiments were performed with cyclo[RGD(DMNPB)fK]. Integrin binding onto 
cyclo[RGD(DMNPB)fK]-modified QCM crystals was much lower than onto the active RGD 
(Figure 3). This result proofs that the DMNPB cage effectively inhibits the activity of the 
RGD peptide. The biggest affinity difference between caged and non-caged RGD (1:6) was 
observed onto RGD modified surfaces on 1% COOH-containing layers. This surface 
composition was used for further studies. 
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Figure 3. Frequency shift observed in QCM experiments upon integrin injection and posterior 
buffer rinsing step on substrates modified with different ratios of cyclo(RGDfK), 
cyclo[RGD(DMNPB)fK] and cyclo(RADfK).  
The integrin binding onto cyclo[RGD(DMNPB)fK]-modified crystals after photocleavage of 
the DMNPB cage was tested with the QCM using a transparent window-cell for insitu light-
exposure. The incubation step with integrin was performed under stop flow in order to 
minimize integrin consumption. Figure 4 shows the corresponding frequency and dissipation 
curves. Initially, the cyclo[RGD(DMNPB)fK]-modified crystal was incubated with the 
integrin solution under stopped flow for 35 minutes. A frequency shift of 10 Hz was observed 
after this incubation time. An additional small shift was detected when the flow was activated 
again, presumably due to the higher integrin concentration of the residual integrin solution 
that remained in the microfluidic tube before the washing step with buffer started. The 
attached integrin could not be removed by washing with buffer or with soluble RGD, 
suggesting that it could be immobilized via non-specific interactions. For the insitu uncaging 
reaction, a LED source was placed above the window-cell and the crystal was illuminated 
under conditions for full cleavage. The irradiation step induced a frequency change of 3 Hz of 
the crystal, but the original resonance frequency value was recovered when the LED was 
turned off. This frequency change has been observed in other cases and has been attributed to 
photoinduced noise.17 After washing with the buffer, the crystal was incubated with integrin 
for further 35 minutes and a frequency shift of 66 Hz was detected. This result indicates that 
surface-bound uncaged cyclo(RGDfK) has a higher affinity (almost 6-fold under our 
conditions) than cyclo[RGD(DMNPB)fK] for integrin binding, confirming that the light-
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triggered uncaging step activates the biological function of cyclo[RGD(DMNPB)fK]. Integrin 
binding onto crystals modified with cyclo(RGDfK) showed a similar frequency shift (70 Hz) 
after incubation for 35 minutes. These results demonstrate that the uncaging reaction at the 
surface worked with high yield and that the presence of photolytic byproducts at the surface 
does not significantly affect the bioactivity of the uncaged peptide in the application. Integrin 
binding to the crystal is also associated with a significant increase in the dissipation curves, as 
expected from the “soft” nature of a surface-attached protein layer. 
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Figure 1 QCM-D shift of frequency (bold lines) and dissipation for experiments on crystals 
modified with cyclo[RGD(DMNPB)fK]. Crystals were first loaded with integrin, followed by 
a washing step, an irradiation step and a second loading of integrin. For comparison integrin 
loading on cyclo(RGDfK) modified crystals is also shown. Note that the incubation step with 
integrin was performed with stopped flow. The small frequency shift observed before the 
buffer washing step is associated to the small volume of integrin solution stored in the tube 
entering the incubation chamber and having higher integrin concentration. 
 
Spatial control of cell attachment: cell micropatterns 
Cyclo[RGDfK] and cyclo[RGD(DMNPB)fK]-terminated SAMs were seeded with HUVECs.  
The RGD sequence in fibronectin was originally shown to be the binding site for endothelial 
cells and this sequence has been demonstrated in fibrinogen, vWF, vitronectin, laminin, 
thrombospondin and type VI collagen.18 Cells rapidly attached and spread onto 
cyclo[RGDfK] already 4 hours after plating, but very poor attachment was observed on the 
cyclo[RGD(DMNPB)fK] substrate even after 5 days of culture (cells remained rounded-up 
and did not spread out).This indicated  that the DMNPB cage effectively inhibited the 
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recognition of the integrins on the cell membrane of the HUVEC cells and prevented cell 
adhesion (Figure 5). However, after irradiation and washing of cyclo[RGD(DMNPB)fK]-
modified substrates, and then adding HUVEC cells, the cells were found to rapidly attach to 
the substrate, and showed a similar pheontype to the cyclo[RGDfK] control. This indicated 
that the DMNPB chromophore was cleaved and cyclo[RGDfK] groups became available and  
functional for cell attachment. 
 
 
Figure 5: HUVECs onto RGD-modified substrates after 4 hours plating (and irradiation in c) 
 
In order to test the possibility to spatially and specifically control cell attachment, 
cyclo[RGD(DMNPB)fK]-functionalized substrates were irradiated through a quartz mask 
containing 100 µm chrome stripes separated by 200 µm and afterwards cells were added. 
HUVECs attached to and spread out selectively on the irradiated regions and formed well 
defined cell patterns (Figure 6). The patterns were maintained over 10 days (see Figure F 
supporting information). HUVECs did not migrate to the regions where the RGD was caged 
and there were clear cutoffs reflecting the mask geometry used in the irradiation step. These 
results suggest a dramatic difference in the affinity of cyclic (RGDfK) and the caged 
derivative for integrin recognition, most probably much higher than the 6 fold difference 
detected by QCM experiments. It is important to note that integrins in solution used for the 
QCM experiments were not in their native environment (i.e. embedded in the cellular lipid 
bilayer) and, therefore, their conformation and functionality could be different than in the 
native state. 
 
Similar experiments were performed with a mouse fibroblast cell line and primary human 
fibroblasts and a human osteoblast cell line. The fibroblasts (NIH3T3) showed less clear 
patterns compared to the HUVEC cells and attachment was not limited to the irradiated region.  
Human osteoblasts (CAL-72) and primary human fibroblasts attached to all regions of the 
substrate in similar amounts, whether irradiated or not (Fig. 6). This is not surprising, since it 
is well known that both of these cell types rapidly attach to normal cell culture plastic 
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substrates and other substrates such as glass without the prior coating with matrix proteins.  
This is in contrast to HUVEC, which generally exhibit very poor attachment to cell culture 
plastic and no attachment to glass substrates without coating with matrix proteins. More cell-
repellent substrate backgrounds than the SAMs (i.e. PEG hydrogels) would most likely be 
required in cases where exclusive RGD-mediated binding is required. 
 
Figure 6: Images of different cell types seeded onto cyclo[RGD(DMNPB)fK] after masked 
irradiation to obtain cell patterns. The indicated cells were added and images were taken after 
24 hrs. 
 
 
Control of RGD surface concentration by the irradiation dose: generation of cell gradients 
Substrates modified with cyclo[RGD(DMNPB)fK] were exposed to a laser beam at different 
irradiation intensities. Linear patterns of 150 µm were written using a laser and irradiation 
doses for which we expected a 25%, 50% or 100% photocleavage of the DMNPB 
chromophore. In this way, a micropattern with a gradient in the concentration of uncaged 
RGD was generated on the surface. HUVECs were seeded onto the patterned substrates in 
order to determine if a difference in adherence pattern was observed, depending on the 
percentage of photocleavage of the DMNPB. Figure7A shows an image of HUVECs 2 hours 
after addition of cells to this substrate. As can be seen, a differing number of cells attached 
and spread out on the different regions depending on the extent of the uncaging reaction. Very 
few HUVEC were observed on the 25%, a few on the 50% and a larger number of cells on the 
100% photocleavaged DMNPB surface.  After 24 hrs, almost no cells remained on the 25% 
(data not shown), cells on the 50% have begun to increase and on the 100% photocleavaged 
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surface, the entire surface was covered with cells.  These images also demonstrate that 
between the photocleavaged areas, rounded-up HUVEC cells could be observed that were in 
the process of detaching.   This indicates that the surface between the photocleavage treated 
areas does not support HUVEC growth. In summary, a direct correlation between 
photocleavage ratio and cell density was visible and the correlation was maintained during the 
24 hour culture period.(Figure 7B). In this way, light-controlled, gradient patterns influencing 
cell attachment and density could be demonstrated. 
 
 
Figure 7:  HUVECs onto cyclo[RGD(DMNPB)fK]-modified surfaces that were scanned with 
a laser with different intensities. A) Three stripes of 150 µm width (marked with discontinous 
lines) were irradiated using exposure doses to achieve 25% (I), 100% (II) and 50% (III) 
uncaging of the DMNPB groups at the surface. The image shows HUVECs 2 hours after 
incubation on those substrates. The differences in cell density reflect the differences in the 
surface concentration of RGD after controlled exposure. B) Microscope image of the 
HUVECs on regions (II) and (III) after 24 hrs incubation. It shows that the differences in cell 
density onto the patterns were maintained over time. Scale bar 100 µm. 
 
Conclusions 
Photoactivatable, caged cyclo[RGD(DMNPB)fK] allows phototriggering of integrin-binding 
events that influence cell attachment to surfaces. The caged peptide showed low affinity for 
integrins. Light exposure removed the DMNPB cage and restored the ability of cells to bind 
integrin and, consequently, mediated cell adhesion. Although only a 6-fold affinity difference 
was measured for soluble integrin between the caged and uncaged peptides, HUVECs showed 
an impressive selective attachment to the uncaged RGD after light treatment, similar to the 
control. Other cell types did not exhibit this characteristic.  In addition, the amount of cells 
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that attach could be controlled, depending on the amount of the photocleaving exposure of the 
substrate.  Thus, a particular cell type could be directed to a specific area of a substrate and 
the amount of cells that attached could be controlled.  Our results demonstrate that surface-
immobilized, caged peptides represent promising tools for new studies in cell biology that 
allow direct and spatiotemporally defined control over molecular interactions with cell 
membrane receptors.These results also indicate that human cells differ in their response to the 
RGD moiety and this information may be valuable in tissue engineering, biomaterial or drug-
targeting strategies. 
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1. Synthesis of DMNPB caged Aspartic acid 
 
The synthesis of DMNPB caged- and Fmoc-protected aspartic acid (f) was done following the 
scheme below by adapting a method described elsewhere.14a 
 
 
 
Materials and methods: 3,4-dimethoxy-acetophenone (a), sodium borohydride, 4-(N,N-
dimethyl)amino-pyridine (DMAP), dry THF, dry acetonitril, methyl iodide, nitronium 
tetrafluoroborate, N,N’-dicyclohexyl-carbodiimide (DCC), trifluoroacetic acid (TFA) (Acros, 
Geel, Belgium), sodium hydride (ABCR GmbH, Karlsruhe, Germany), α-tert-butyl N-Fmoc-
L-aspartate (Bachem, Bubendorf, Switzerland) were bought and used without any other 
purification. 
1H-NMR spectra were measured at room temperature with Brucker Avance 250 (250 MHz) 
and Brucker Avance 700 (700 MHz) spectrometers. ESI-MS spectra were recorded using a 
QTos Ultima 3. HPLC analysis and purification of the compounds was performed with a 
JASCO HPLC 2000 equipped with a diode array UV-Vis detector and fraction collector. 
Reprosil C18 columns were used for semi-preparative (250 × 25 mm) and analytical (250 × 5 
mm) runs. 
 
3-(3,4-dimethoxyphenyl)-butan-2-one, (b): 1.94 g  of a (10 mmol, 1 equiv.) were poured 
dropwise at r.t.  to a suspension of sodium hydride (0.4 g NaH 60% in paraffin suspesion, 10 
mmol, 1 equiv.) in 25 ml dry THF. After 30 minutes stirring at r.t., the suspension was cooled 
to 0°C and 0.75 ml methyl iodide (11.9 mmol, 1.19 equiv.) were added. After stirring at 0°C 
for 30 minutes, the cooling bath was removed and the reaction mixture was stirred 1 hour at 
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r.t. Then, 100 ml of saturated solution of NaHCO3 were added, the aqueous layer was 
extracted twice with 100 ml ethyl acetate, the combined organic layers were washed with 
brine and dried over MgSO4, and the solvent was removed in vacuum to afford the crude 
product as pale yellow oil (1.98 g, yield 96%).  
 
3-(3,4-dimethoxyphenyl)-butan-2-ol, (c): 500 mg sodium borohydride (13.1 mmol, 1.4 
equiv.) were added at r.t. to a solution of 1.9 g of b (9.1 mmol, 1 equiv.) in 10 ml THF and 20 
ml 2-propanol, and the resulted suspension was stirred at r.t. for 1 hr. The unreacted sodium 
borohydride was quenched with 1M aqueous HCl. To the reaction mixture 200ml water and 
100 ml ethyl acetate were added and the aqueous layer was extracted with 100 ml ethyl 
acetate. The combined organic layers were washed with water and brine, and were dried over 
MgSO4. The solvent was removed in vacuum to afford the crude product as pale yellow oil. 
The crude product was purified via column chromatography (silicagel, 3:1 hexane/acetone) to 
afford the product as a erythro-threo mixture (1.9 g, 99% yield). 
 
3-(4,5-dimethoxy-2-nitro-phenyl)-butan-2-ol, (d): 0.9 g nitronium tetrafluoroborate (6.8 
mmol, 1.4 equiv.) were dissolved at -30°C in 15 ml of dry acetonitril and 0.7 ml 2-picoline 
(7.2 mmol) were added dropwise. After 30 minutes, a solution of 1g of c (4.7 mmol, 1 equiv.) 
in 10 ml dry acetonitril was slowly added and the reaction mixture was stirred 1 hour at -30°C 
and overnight at r.t. The unreacted nitronium complex was quenched with 100 ml of saturated 
solution of sodium bicarbonate and the aqueous layer was extracted twice with 100 ml ethyl 
acetate. The combined organic layers were washed with 100 ml water, brine and the solvent 
was removed in vacuum. The brown residue was purified via column chromatography 
(silicagel, 2:1 hexane/acetone) to give 0.74 g (61% yield) of the d as erythro-threo isomers 
mixture. 
 
α-tert-butyl δ-[3-(4,5-dimethoxy-2-nitro-phenyl)-2-butyl]-N-Fmoc-L-aspartate, (e): To a 
solution of 255 mg d (1 mmol, 1 equiv.) in 10 ml dry dichloromethane were added, in the 
following order, α-tert-butyl N-Fmoc-L-aspartate (411 mg, 1 mmol, 1 equiv.), DCC (200 mg, 
1 mmol, 1 equiv.) and DMAP (10 mg, 81 µmol, 0.08 equiv.). After the reaction mixture was 
stirred overnight under Ar at r.t., 100 ml saturated sodium bicarbonate solution were added, 
the aqueous layer was extracted twice with 100 ml ethyl acetate, combined organic layers 
were washed with 100 ml water, dried with brine and over MgSO4, and the solvent was 
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removed in vacuum. The brown residue was purified via column chromatography (silicagel, 
4:1 hexane/acetone) to give 455 mg (70% yield) of the d as erythro-threo isomers mixture. 
Fehler! Es ist nicht möglich, durch die Bearbeitung von Feldfunktionen Objekte zu 
erstellen. 
1H-NMR (CDCl3, 250 MHz) δ (ppm): 1.23-1.26 (3H, m, -CH3 e); 1.29-1.33 (3H, m, -CH3 d); 
1.42-1.47 (9H, m, -CH3 OtBu); 2.60-2.98 (2H, m, CH2 b); 3.72-3.97 (7H, OCH3 meta, OCH3 
para, CH f); 4.22-4.50 (4H, m, CH c, CH j, CH2 i); 5.14-5.30 (1H, m, CH a); 5.57-5.76 (1H, 
m, NH); 6.876-6.88 (1H, m, CH h); 7.3-7.42 (5H, m, CH g, CH l, CH m); 7.54-7.59 (2H, m, 
CH k); 7.76 (2H, d, 3J=7.5 Hz, CH n). 
ESI-MS: 648 (M+). 
 
α-tert-butyl δ-[3-(4,5-dimethoxy-2-nitro-phenyl)-2-butyl]-L-aspartate, (f): 200 mg of e 
were dissolved in 2 ml DCM:TFA (1:1) mixture and the solution was stirred under Ar at r.t. 
for 1 hour. After the solvent was removed using a nitrogen stream, 5 ml of DCM were added, 
and the solution was dried again under the nitrogen stream. The yellow-brown residue was 
dissolved in acetonitril and purified by HPLC (water:ACN, gradient from 50% ACN to 100% 
ACN), resulting 170 mg (93% yield) of f as yellow solid.  
Fehler! Es ist nicht möglich, durch die Bearbeitung von Feldfunktionen Objekte zu 
erstellen. 
1H-NMR (CDCl3, 250 MHz) δ (ppm): 1.23-1.26 (3H, m, -CH3 e); 1.29-1.33 (3H, m, -CH3 d); 
2.54-2.91 (2H, m, CH2 b); 3.72-3.97 (7H, OCH3 meta, OCH3 para, CH f); 4.22-4.50 (4H, m, 
CH c, CH j, CH2 i); 4.46-4.61 (1H, m, CH a); 5.51-5.70 (1H, m, NH); 6.86-6.88 (1H, m, CH 
h); 7.30-7.42 (5H, m, CH g, CH l, CH m); 7.54-7.59 (2H, m, CH k); 7.76 (2H, d, 3J=7.5 Hz, 
CH n). 
ESI-MS: 615.24 (M+Na)+ 
 
2. Synthesis of cyclo[RGD(DMNPB)fK] via SPPS 
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Materials and methods: Chemicals and solvents were purchased from Sigma-Aldrich 
Chemie GmbH (D-89555), Acros Organics (Geel, Belgium), Bachem Distribution Services 
GmbH (79576-Weil am Rhein) and Merck KGaA (D-64271). Solvents had p.a. purity and 
were used as obtained unless specified. Solid phase peptide synthesis (SSPS) was performed 
using syringes of 5 ml and 10 ml volume as reaction vessels equipped with PE-filters (CEL-
053 and CEL-1016), Roland Vetter Laborbedarf OHG, Ammerbuch) for washing steps. 
Trityl-linker resin (TCP-resin, 1,4-1,5 mmol Cl/g, 100-200 mesh) was obtained from 
PepChem Intavis AG Bioanalytical Instruments (D-72770 Reutlingen). 
 
Coupling of Fmoc-Gly-OH: A syringe was weighed and filled with TCP-resin. A solution of 
1.1 eq. of Fmoc-Gly-OH and 5.6 eq. of N,N-Diisopropylethylamine (DIPEA) in absolute 
DCM (8 ml/g of resin) was added, and the suspension was vigorously shaked in the syringe 
for 1.5 hours. MeOH (1ml / g of resin) was added and the mixture was shaked for further 20 
min. The solution was filtered out and the resin was washed with DCM, three times with 
DMF, three times with DCM and twice with MeOH. The resin was left in a desiccator filled 
with silica gel under vacuum overnight for drying. The amino acid loading on the resin could 
be calculated as follows. 
Fehler! Es ist nicht möglich, durch die Bearbeitung von Feldfunktionen Objekte zu 
erstellen.   
 
n loading density [mmol AA/g loaded resin] 
m1 weight of untreated resin [g] 
m2 weight of loaded resin [g] 
MAA molecular weight of Fmoc-AA [g/mol] 
MHCl 36,46 g/mol    
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Synthesis of linear H-Asp(DMNPB)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH: The preparation 
of the linear peptide follows the Fmoc-strategy (Table 1)  and started from 0.19 mmol of Gly-
loaded resin. Deprotection of the Fmoc-group was performed by reacting the resin twice for 
10 minutes with 20% piperidine in DMF under vigorous shaking. The resin was washed five 
times with DMF. To couple the next amino acid, a solution of the Fmoc-amino acid, HOBt, 
HBTU, and DIPEA in DMF (10-15 ml/g of resin) was added to the reaction vessel and left to 
react under vigorous shaking.  The coupling conditions for each of the Fmoc-amino acids 
(Arg(Pbf), Lys(Boc), D-Phe and Asp(DMNPB)) are specified in Table 1. The coupling 
solution was then filtered out and the resin was washed five times with DMF.  
Cleavage of the protected linear peptide from the resin was performed by treating the resin 
once with 1.5 ml and twice with 3 ml of a solution of trifluorethanol/acetic acid/DCM (1/3/6) 
for 30 min each. Toluene was added to the filtrate and the solvents were removed in vacuum. 
119 mg (0.1 mmoles) of crude product was obtained from 0.19 mmoles of TCP-resin. 
 
Table 1. Solid Phase Peptide Synthesis using Fmoc-strategy 
Step Reagent / solvent Time Cycle 
1 20% Piperidine / DMF 10 min Deprotection 
2 20% Piperidine / DMF 10 min Deprotection 
3 DMF  5 x washing 
4 Coupling solution (*) min Coupling 
5 DMF  5 x washing 
 
(*)  Fmoc-Arg(Pbf)-OH (3h), Fmoc-Lys(Boc)-OH (3h), Fmoc-D-Phe-OH (3,5 h),  
 Fmoc-Asp(DMNPB)-OH (4 h) 
 
 
Table 2. Coupling conditions for the different aminoacids 
  Arg(Pbf) Lys(Boc) D-Phe Asp(DMNPB) 
Fmoc-amino acid / eq. 2 2 2.5 1.3 
HOBT / eq. 2 2 2.5 1.3 
HBTU / eq. 2 2 2.5 1.4 
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DIPEA / eq. 6 6 7 5 
DMF / ml 1.7 1.7 2 2.3 
 
 
Synthesis of Cyclo[-Asp(DMNPB)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-]: The cyclization of the 
protected linear peptide was performed in solution using diphenylphosphoryl azide (DPPA) as 
coupling reagent. The protected peptide (119 mg, 0.1 mmoles) was dissolved in DMF (20 ml, 
c = 5 mM). NaHCO3 (42.2 mg, 0.5 mmoles) and DPPA (64 µl, 0.3 mmoles) were added and 
the reaction mixture was stirred at room temperature for a period of 48 hours. After filtering 
off the NaHCO3, the solution was concentrated at 40°C using high vacuum. The cyclo 
peptide was precipitated in water and dried in high vacuum to give 0.1 mmoles of crude 
product. Yield 99 %. 
 
Hydrolysis of protecting groups: Cyclo[-Asp(DMNPB)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-] 
(0.1 mmoles) was dissolved in 800 µl of TFA/H2O (760 µl/40µl) and stirred for 1.5 hours. 
Solvent was evaporated to 20% of the initial volume and 15 ml diisopropyl ether were added. 
The precipitate was centrifuged and dried in high vacuum to give 96 mg (0.1 mmoles) of 
crude product. 
 
HPLC purification: The crude product was purified twice by RP-HPLC using 
water/acetonitrile containing 0.1% TFA as eluents. By increasing the volume fraction of 
acetonitrile after a 3 min run from 10% to 40% within 15 min and successively keeping this 
ratio for another 9 min the product signal appears between 18 and 19 min. The pure fractions 
were collected and freeze dried to give a yellow powder. 35 mg (0.04 mmoles) of solid were 
obtained from 96 mg of crude product. Yield 36.5%. MS ES+: 841.40. 
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Figure A. 1H-NMR spectrum of cyclo[RGD(DMNPB)fK] in D2O (700MHz) 
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Figure B: IR spectrum of cyclo[RGD(DMNPB)fK] 
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Figure C. Analytical HPLC chromatogram of the synthesized cyclo[RGD(DMNPB)fK], of 
commercially available cyclo[RGDfK], and of 2.17 mM solution of cyclo[RGD(DMNPB)fK 
after light exposure for 26 and 90 minutes at 360 nm in PBS buffer (pH 7.4). 
 
 
3. Synthesis of DMNPB caged COOH-terminated silane and 
preparation and characterization of surface layers 
 
 
 
3-(4-5-dimethoxy-2-nitro-phenyl)-butan-2-yl-but-3-enoate: Butenoic acid (91 µL, 1.06 
mmol, 1 equiv.) was added to a solution of 3-(4-5-dimethoxy-2-nitro-phenyl)-butan-2-ol (270 
mg, 1.06 mmol, 1 equiv.) in 15 ml dry dichloromethane, which was cooled to 0 °C. Then, the 
addition of DCC (220 mg, 1.06 mmol, 1 equiv.) dissolved in CH2Cl2 dry (10 mL) was 
followed dropwise for 10 min. Finally, DMAP (10 mg, 85 µmol, 0.08 equiv.) was added to 
the solution. The reaction mixture was allowed to reach room temperature and after that the 
mixture was stirred overnight under Ar. Thin layer chromatography (TLC) indicated that the 
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reaction was complete. The mixture was neutralized with 200 ml saturated sodium 
bicarbonate solution and the aqueous layer was extracted with 50 ml dichloromethane. The 
combined organic layers were washed with 100 ml water and brine (2x100 mL), dried over 
MgSO4, and the solvent was removed in vacuum. The residue was purified via column 
chromatography (silicagel, 3:1 hexane/ethyl acetate) to give 141 mg (41% yield) of the 
product. 
1H-NMR (CDCl3, 250 MHz) δ (ppm): 1.24-1.29 (3H, m, -CH3 f); 1.30-1.34 (3H, m, -CH3 e); 
3.05-3.12 (2H, m, CH2 c); 3.78 (1H, m, CH g); 3.93 (6H, m, 2xOCH3 j); 5.18 (2H, m, CH2 a); 
5.63 (1H, m, CH b); 6.84 (1H, m, Ar-H h); 7.37 (1H, m, Ar-H i). 
3-(4-5-dimethoxy-2-nitro-phenyl)-butan-2-yl-4-(triethoxysilyl)butanoate: 3-(4-5-
dimethoxy-2-nitro-phenyl)-butan-2-yl-but-3-enoate (140 mg, 0.43 mmol, 1 equiv.) and 
triethoxysilane (0.8 mL, 4.30 mmol, 10 equiv.) were placed into a previously HMDS-
passivated19 dry, round-bottomed flask and heated to 80 °C under argon atmosphere. After 
addition of an isopropanolic H2PtCl6 solution (22 L, 65 mM), the mixture was stirred for 3 
hours at 80 °C and then allowed to cool. Excess of triethoxysilane was removed in vacuum, 
and the residue was taken up in dichloromethane and filtered through Celite500. The filtrate 
was concentrated under reduced pressure and determined to be the desired silane. 
1H-NMR (CDCl3, 250 MHz) δ (ppm): 0.45 – 0.46 (2H, m, CH2 a); 1.22 (9H, m, 3xCH3 k); 
1.29 (3H, m, -CH3 f); 1.32 (3H, m, -CH3 e); 2.21 (2H, m, CH2 b); 2.34 (2H, m, CH2 c); 3.60-
4.00 (12H, m, 3xCH2 l, 2xOCH3 j); 4.24 (1H, m, CH g); 6.84 (1H, m, Ar-H h); 7.37 (1H, m, 
Ar-H i). 
Surface Modification: A 1% w/v solution of the photosensitive silane in THF with 30 µl of 1 
N NaOH (aq.) was stirred during 30 min. The solution was filtrated through a 0.2 m pore-
size PTFE filter in the reaction vessel, and clean substrates were immersed in it. After reaction, 
the substrates were rinsed with THF and Milli-Q water and baked for 1 h at 90 ºC in a vacuum 
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oven and stored in the dark. Experiments with increasing catalyst concentration and 
deposition times were performed to obtain layers with a maximum density of functional 
groups (as revealed by UV spectroscopy). Before further application, all substrates were 
sonicated in THF for 3 min, washed with Milli-Q water and dried under N2 stream. 
 
Characterisation of the density of chromophore 
The surface density of the chromophore, Γ (molecs cm-2), can be estimated from the UV 
absorbance using Γ = ½ [Aλελ-1NA] x 10-3, where Aλ is the absorbance of the surface layer at a 
given wavelength, ελ is the molar extinction coefficient of the chromophore in solution at λ 
(ε346=4100 M-1 cm-1, λmax=346 nm), and NA is Avogadro’s number.20 The factor ½ refers to 
the fact that the quartz slides are modified on both sides. 
 
Photolysis experiments at the surface: Irradiation of the substrates was carried out using a 
LED (Edmund Optics) as monochromatic light source. The wavelength and irradiance used 
were 365 nm and 4.5 mW cm-2 respectively. After irradiation, substrates were sonicated in 
THF and rinsed with Milli-Q water before recording UV-Vis spectra. 
 
 
4. QCM Experiments 
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Figure D. QCM frequency shift corresponding to Integrin absorption onto a 4% -COOH 
terminated SAM functionalized with cyclo[RGDfK]. The concentration of integrin solution 
was 2 µg/mL, 20 µg/mL and 200 µg/mL. 
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Figure E. Frequency  shift and dissipation values observed in QCM-D experiments in the 
absence of Mn2+ and Mg2+ in the buffer solution upon integrin injection for substrates 
modified with a 1% -COOH terminated SAM functionalized with cyclo(RGDfK). 
5. Cell images
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Figure F: HUVECs on cyclo[RGD(DMNPB)fK] modified substrates after masked irradiation 
after culture for 1-10 days. 
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